Daratumumab in rituximab-refractory autoimmune haemolytic anaemia

Br J Haematol. 2021 Sep;194(5):931-934. doi: 10.1111/bjh.17655. Epub 2021 Jun 28.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anemia, Hemolytic, Autoimmune / drug therapy*
  • Antibodies, Monoclonal / therapeutic use*
  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Rituximab / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Immunologic Factors
  • Rituximab
  • daratumumab